1-(2-(4-(Tert-butoxycarbonyl)piperazin-1-yl)ethyl)piperidine-4-carboxylic acid, 95+%, 1g

Methyl 2-(2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate, 98%, 250mg

Syringe filters Minisart® NML Non-sterile, 0,8 µm, 500 Piece(s)

methyl (1S,3S)-rel-3-bromocyclopentane-1-carboxylate, 97.0%, 250mg

4,4,5,5-Tetramethyl-2-[3-(trifluoromethyl)phenyl]-1,3,2-dioxaborolane>98.0%(GC)(T)25g

Methyl-4-[(1S)-1-aminoethyl] benzoate, 98.0%, 10g

1-(3-Chlorophenyl)-2,2-difluoroethan-1-one, 97%, 250mg

2-(TERT-BUTOXYCARBONYL)-5-THIA-2-AZASPIRO[3.4]OCTANE-8-CARBOXYLIC ACID 5,5-DIOXIDE, 95.0%, 500mg

NN-Bis(2-hydroxyethyl)-2-naphthylamine, 2g

2,2,6,6-Tetramethylpiperidinoxy free radical, 99.0%, 25g

5-Bromo-2-(4-nitrophenyl)-7-azabenzimidazole, 1g

6-(1H-imidazol-2-yl)nicotinic acid, 98%, 500mg

4-Vinylbenzenesulfonamide, 97% mix TBC as stabilizer, 250mg